Catabasis Pharmaceuticals
Why Robinhood?
You can watch CATB and buy or sell other stocks, ETFs, and their options commission-free!About CATB
Catabasis Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of novel therapeutics. Its lead product candidate is edasalonexent, which is intended for the treatment of Duchenne muscular dystrophy.
CATB Key Statistics
Stock Snapshot
Catabasis Pharmaceuticals(CATB) stock is priced at $14.47, giving the company a market capitalization of 1.13B.
During the trading day, Catabasis Pharmaceuticals(CATB) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading activity shows a volume of 0, compared to an average daily volume of 508.7K.
Over the past 52 weeks, Catabasis Pharmaceuticals(CATB) stock has traded between a high of $8.59 and a low of $1.20.
Over the past 52 weeks, Catabasis Pharmaceuticals(CATB) stock has traded between a high of $8.59 and a low of $1.20.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.